LONGEVITY with Nathalie Niddam avatar

Dexa/LONGEVITY with Nathalie Niddam

Learn more

Weight Loss Medications

GLP-1 agonists, such as ozempic and wagovi, are gaining attention for their dual role in managing diabetes and aiding weight loss. The importance of gradually increasing dosage is emphasized, as it can mitigate side effects like nausea, which some individuals may experience more intensely than others. The high cost of these medications raises questions about accessibility and the pharmaceutical company's investment recovery.
  • In this clip

  • From this podcast

    LONGEVITY with Nathalie Niddam avatar

    LONGEVITY with Nathalie Niddam

    Episode #77: Semaglutide, A GLP-1 Agonist, Showing Success With Weight Loss and Type 2 Diabetes

  • Related Questions

    • How does semaglutide compare to other weight-loss drugs?

    • Is it better for someone to adopt a whole food diet, strength training, and eat in a specific caloric range for their goal, or to start with a GLP-1 medication like Semaglutide straight away for weight loss? If they choose the medication, in what ways could it be beneficial or detrimental in the context of the episodes Why OZEMPIC Will NOT Solve Your Fat Loss Problems | Mind Pump 2058 and Weight Loss Realities?

    • At what point should someone consider using a GLP-1 like Semaglutide, and how is Semaglutide beneficial or detrimental to a sustainable weight loss scenario that promotes health, as discussed in the episode Why OZEMPIC Will NOT Solve Your Fat Loss Problems | Mind Pump 2058 and the clip Weight Loss Realities?

Built by
Charlie AI
© 2024 LONGEVITY with Nathalie NiddamTermsPrivacySupport